

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.28238620 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.66765319 |
| 3 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.41149628 |
| 4 | * L-phenylalanine catabolic process (GO:0006559) | 7.41149628 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.40275756 |
| 6 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07148860 |
| 7 | * L-phenylalanine metabolic process (GO:0006558) | 7.07148860 |
| 8 | * aromatic amino acid family catabolic process (GO:0009074) | 6.74345920 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.38516942 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.21294336 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.21294336 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.21294336 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.06650705 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.94207038 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.85268025 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.83865774 |
| 17 | urea cycle (GO:0000050) | 5.79085903 |
| 18 | urea metabolic process (GO:0019627) | 5.79085903 |
| 19 | regulation of plasminogen activation (GO:0010755) | 5.68168161 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.61753725 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60771478 |
| 22 | drug metabolic process (GO:0017144) | 5.58000139 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.57702541 |
| 24 | cysteine metabolic process (GO:0006534) | 5.46240668 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.43101316 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.36194767 |
| 27 | oxidative demethylation (GO:0070989) | 5.35014361 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.33295951 |
| 29 | protein carboxylation (GO:0018214) | 5.33295951 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.32794766 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.25153031 |
| 32 | ethanol metabolic process (GO:0006067) | 5.19741982 |
| 33 | complement activation, alternative pathway (GO:0006957) | 5.16509901 |
| 34 | regulation of protein activation cascade (GO:2000257) | 5.15826353 |
| 35 | bile acid metabolic process (GO:0008206) | 5.09618430 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.93734041 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.90709564 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88675667 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.87907989 |
| 40 | negative regulation of protein activation cascade (GO:2000258) | 4.85931269 |
| 41 | * aromatic amino acid family metabolic process (GO:0009072) | 4.84358064 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.82776342 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.80164439 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.80164439 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.80164439 |
| 46 | regulation of complement activation (GO:0030449) | 4.79609920 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.77225490 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.77225490 |
| 49 | phenylpropanoid metabolic process (GO:0009698) | 4.77123672 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.70456935 |
| 51 | lysine metabolic process (GO:0006553) | 4.70066807 |
| 52 | lysine catabolic process (GO:0006554) | 4.70066807 |
| 53 | acute-phase response (GO:0006953) | 4.69265273 |
| 54 | * alpha-amino acid catabolic process (GO:1901606) | 4.67242837 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.63782709 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.63782709 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.61031016 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.61031016 |
| 59 | phospholipid efflux (GO:0033700) | 4.60652081 |
| 60 | S-adenosylmethionine metabolic process (GO:0046500) | 4.59246269 |
| 61 | intestinal cholesterol absorption (GO:0030299) | 4.59078425 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.52907384 |
| 63 | regulation of humoral immune response (GO:0002920) | 4.49111749 |
| 64 | glycine metabolic process (GO:0006544) | 4.45570579 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.40784845 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.40623692 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.39594566 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.38080049 |
| 69 | bile acid and bile salt transport (GO:0015721) | 4.37443066 |
| 70 | negative regulation of coagulation (GO:0050819) | 4.34619593 |
| 71 | glutamate metabolic process (GO:0006536) | 4.32076426 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.31342037 |
| 73 | amine catabolic process (GO:0009310) | 4.31342037 |
| 74 | * cellular amino acid catabolic process (GO:0009063) | 4.30410528 |
| 75 | cellular glucuronidation (GO:0052695) | 4.26363305 |
| 76 | negative regulation of wound healing (GO:0061045) | 4.26048003 |
| 77 | * tyrosine metabolic process (GO:0006570) | 4.25373238 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 4.25018986 |
| 79 | cholesterol efflux (GO:0033344) | 4.22707381 |
| 80 | positive regulation of hemostasis (GO:1900048) | 4.19647671 |
| 81 | positive regulation of blood coagulation (GO:0030194) | 4.19647671 |
| 82 | negative regulation of complement activation (GO:0045916) | 4.18955488 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.15718745 |
| 84 | alkaloid metabolic process (GO:0009820) | 4.14356249 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 4.13168312 |
| 86 | arginine metabolic process (GO:0006525) | 4.11663746 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 4.09485702 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.07899761 |
| 89 | ethanol oxidation (GO:0006069) | 4.07135077 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06431981 |
| 91 | aldehyde catabolic process (GO:0046185) | 4.05948367 |
| 92 | drug catabolic process (GO:0042737) | 4.05526799 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 4.01738437 |
| 94 | response to mercury ion (GO:0046689) | 3.99778568 |
| 95 | fibrinolysis (GO:0042730) | 3.96759250 |
| 96 | cytolysis (GO:0019835) | 3.92750265 |
| 97 | ketone body metabolic process (GO:1902224) | 3.92119156 |
| 98 | positive regulation of coagulation (GO:0050820) | 3.84537555 |
| 99 | opsonization (GO:0008228) | 3.81159677 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.80711822 |
| 101 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.79107336 |
| 102 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.79107336 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.79003729 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.79003729 |
| 105 | negative regulation of lipase activity (GO:0060192) | 3.78797618 |
| 106 | cofactor catabolic process (GO:0051187) | 3.78546342 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.77787795 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.77787795 |
| 109 | * organic acid catabolic process (GO:0016054) | 3.77139176 |
| 110 | * carboxylic acid catabolic process (GO:0046395) | 3.77139176 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75631492 |
| 112 | positive regulation of lipid catabolic process (GO:0050996) | 3.75266059 |
| 113 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73955268 |
| 114 | short-chain fatty acid metabolic process (GO:0046459) | 3.73876576 |
| 115 | cholesterol homeostasis (GO:0042632) | 3.73785196 |
| 116 | phospholipid homeostasis (GO:0055091) | 3.72592223 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.69458899 |
| 118 | sterol homeostasis (GO:0055092) | 3.67785729 |
| 119 | complement activation, classical pathway (GO:0006958) | 3.64042347 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.63794175 |
| 121 | plasma lipoprotein particle organization (GO:0071827) | 3.63588842 |
| 122 | protein activation cascade (GO:0072376) | 3.63150813 |
| 123 | complement activation (GO:0006956) | 3.62116884 |
| 124 | protein-lipid complex assembly (GO:0065005) | 3.60279825 |
| 125 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.59365403 |
| 126 | regulation of apoptotic cell clearance (GO:2000425) | 3.58765715 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.58338809 |
| 128 | acute inflammatory response (GO:0002526) | 3.55932513 |
| 129 | flavonoid metabolic process (GO:0009812) | 3.54820703 |
| 130 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54709957 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.54507785 |
| 132 | hormone catabolic process (GO:0042447) | 3.54405940 |
| 133 | protein-lipid complex subunit organization (GO:0071825) | 3.52663347 |
| 134 | doxorubicin metabolic process (GO:0044598) | 3.51831497 |
| 135 | daunorubicin metabolic process (GO:0044597) | 3.51831497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41982649 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19118537 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.98144412 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50253531 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32091491 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11644391 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.87445313 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02584152 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.00381617 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09465695 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0011247 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98800404 |
| 13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94669738 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58756537 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54906487 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54508804 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40422715 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38252890 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36371187 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27377441 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20321063 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19048203 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17852719 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15974300 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04801195 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01696817 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01617078 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97030937 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94597455 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91525108 |
| 31 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86472914 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85978377 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84135312 |
| 34 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83816647 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82199955 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82195749 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81651956 |
| 38 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78082693 |
| 39 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77358984 |
| 40 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76920879 |
| 41 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76568552 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76440216 |
| 43 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74884854 |
| 44 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74128913 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.73807318 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73429500 |
| 47 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73291981 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72223352 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.71397003 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71173948 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70031217 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.67660744 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66866587 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66437983 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65625877 |
| 56 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.64792289 |
| 57 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64654505 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63491564 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63486425 |
| 60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63335943 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63335943 |
| 62 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62945499 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62778445 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62434204 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.62190695 |
| 66 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.60865776 |
| 67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60670304 |
| 68 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59542981 |
| 69 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.59459896 |
| 70 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.58110890 |
| 71 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57412568 |
| 72 | SA1_27219007_Chip-Seq_Bcells_Human | 0.56907888 |
| 73 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.56894452 |
| 74 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.55787314 |
| 75 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.55475273 |
| 76 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.55402468 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55304521 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55217329 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.55143116 |
| 80 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55075318 |
| 81 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.54177930 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.53840851 |
| 83 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.53567631 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 0.53130451 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52912890 |
| 86 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52610119 |
| 87 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51617019 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51251007 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51179641 |
| 90 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.50725750 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50541322 |
| 92 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49152677 |
| 93 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49097535 |
| 94 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.48828753 |
| 95 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48350750 |
| 96 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.47621970 |
| 97 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47602082 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47014220 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.46958707 |
| 100 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46784298 |
| 101 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45815129 |
| 102 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.45377594 |
| 103 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.45289585 |
| 104 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.45128517 |
| 105 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.45086913 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45013121 |
| 107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44808672 |
| 108 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.44014996 |
| 109 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.43908969 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43888422 |
| 111 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43859193 |
| 112 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.43505036 |
| 113 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43408090 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42605533 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41993406 |
| 116 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41929921 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41160574 |
| 118 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.40995059 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40850238 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40758173 |
| 121 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39718605 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39517366 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39330431 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39057163 |
| 125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38666734 |
| 126 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37787935 |
| 127 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37534657 |
| 128 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.37368815 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37238257 |
| 130 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36715048 |
| 131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35419100 |
| 132 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34113430 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34096523 |
| 134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34076548 |
| 135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33650669 |
| 136 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33081500 |
| 137 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.32933957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.33245624 |
| 2 | MP0005360_urolithiasis | 7.61376626 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.41392878 |
| 4 | MP0005365_abnormal_bile_salt | 6.17289777 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.19683844 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.23592229 |
| 7 | MP0003252_abnormal_bile_duct | 3.89743158 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57805723 |
| 9 | MP0009840_abnormal_foam_cell | 3.31442532 |
| 10 | MP0005083_abnormal_biliary_tract | 3.04588037 |
| 11 | MP0003195_calcinosis | 2.91417712 |
| 12 | * MP0005332_abnormal_amino_acid | 2.75813785 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.57247869 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.31085210 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.19528766 |
| 16 | MP0000609_abnormal_liver_physiology | 2.15373773 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09972405 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00996499 |
| 19 | MP0003868_abnormal_feces_composition | 1.90429613 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83138982 |
| 21 | MP0001764_abnormal_homeostasis | 1.69250312 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58553599 |
| 23 | MP0009697_abnormal_copulation | 1.58464851 |
| 24 | MP0005451_abnormal_body_composition | 1.56730966 |
| 25 | MP0003011_delayed_dark_adaptation | 1.35651943 |
| 26 | MP0003186_abnormal_redox_activity | 1.29608571 |
| 27 | MP0002132_abnormal_respiratory_system | 1.25251961 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.24052201 |
| 29 | * MP0009643_abnormal_urine_homeostasis | 1.22508817 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17328241 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.15028620 |
| 32 | MP0005647_abnormal_sex_gland | 1.11164563 |
| 33 | MP0001915_intracranial_hemorrhage | 1.10173616 |
| 34 | MP0000604_amyloidosis | 1.08599491 |
| 35 | MP0009764_decreased_sensitivity_to | 1.05997438 |
| 36 | MP0009763_increased_sensitivity_to | 1.00615786 |
| 37 | MP0002254_reproductive_system_inflammat | 0.98336875 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.95142775 |
| 39 | MP0010368_abnormal_lymphatic_system | 0.92123232 |
| 40 | MP0008469_abnormal_protein_level | 0.87851827 |
| 41 | * MP0009642_abnormal_blood_homeostasis | 0.86408638 |
| 42 | MP0005408_hypopigmentation | 0.85205113 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.83991892 |
| 44 | MP0003879_abnormal_hair_cell | 0.83952655 |
| 45 | MP0005670_abnormal_white_adipose | 0.80058726 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.79963833 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 0.78279328 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.77794883 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.77567529 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 0.76020504 |
| 51 | MP0002971_abnormal_brown_adipose | 0.71743484 |
| 52 | MP0005220_abnormal_exocrine_pancreas | 0.69857720 |
| 53 | MP0004130_abnormal_muscle_cell | 0.68212031 |
| 54 | MP0005334_abnormal_fat_pad | 0.68170671 |
| 55 | MP0001661_extended_life_span | 0.67674446 |
| 56 | MP0003690_abnormal_glial_cell | 0.67515016 |
| 57 | MP0005535_abnormal_body_temperature | 0.67414474 |
| 58 | MP0000566_synostosis | 0.66548678 |
| 59 | MP0009053_abnormal_anal_canal | 0.65311596 |
| 60 | MP0003329_amyloid_beta_deposits | 0.64962137 |
| 61 | MP0005266_abnormal_metabolism | 0.64784832 |
| 62 | MP0001756_abnormal_urination | 0.63620590 |
| 63 | MP0002282_abnormal_trachea_morphology | 0.62828911 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.59949964 |
| 65 | MP0005187_abnormal_penis_morphology | 0.58682475 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 0.57046757 |
| 67 | MP0005448_abnormal_energy_balance | 0.54968499 |
| 68 | MP0002249_abnormal_larynx_morphology | 0.54654540 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.52151778 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 0.50863593 |
| 71 | MP0002822_catalepsy | 0.50516746 |
| 72 | MP0005395_other_phenotype | 0.48947585 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.48561254 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.47430050 |
| 75 | MP0008874_decreased_physiological_sensi | 0.47106239 |
| 76 | MP0003718_maternal_effect | 0.45353714 |
| 77 | MP0002928_abnormal_bile_duct | 0.45011710 |
| 78 | MP0008873_increased_physiological_sensi | 0.44763799 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.43789891 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 0.42787285 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.42757460 |
| 82 | MP0005023_abnormal_wound_healing | 0.42267161 |
| 83 | MP0003953_abnormal_hormone_level | 0.40962256 |
| 84 | MP0003075_altered_response_to | 0.40902338 |
| 85 | MP0003724_increased_susceptibility_to | 0.40736007 |
| 86 | MP0003436_decreased_susceptibility_to | 0.40551429 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.40113774 |
| 88 | MP0008872_abnormal_physiological_respon | 0.39275217 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.37922475 |
| 90 | MP0009672_abnormal_birth_weight | 0.37296002 |
| 91 | MP0005166_decreased_susceptibility_to | 0.36347812 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.33845422 |
| 93 | MP0004381_abnormal_hair_follicle | 0.33577298 |
| 94 | MP0002168_other_aberrant_phenotype | 0.32743110 |
| 95 | MP0009115_abnormal_fat_cell | 0.32488524 |
| 96 | MP0000249_abnormal_blood_vessel | 0.32156272 |
| 97 | MP0006082_CNS_inflammation | 0.31522253 |
| 98 | MP0001243_abnormal_dermal_layer | 0.31511266 |
| 99 | MP0004883_abnormal_blood_vessel | 0.31226140 |
| 100 | MP0002796_impaired_skin_barrier | 0.31098362 |
| 101 | MP0000579_abnormal_nail_morphology | 0.30812883 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.30750660 |
| 103 | MP0003122_maternal_imprinting | 0.30119934 |
| 104 | MP0002697_abnormal_eye_size | 0.29950017 |
| 105 | MP0002970_abnormal_white_adipose | 0.29870125 |
| 106 | MP0001853_heart_inflammation | 0.28972840 |
| 107 | MP0009785_altered_susceptibility_to | 0.28823983 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.27631260 |
| 109 | MP0004272_abnormal_basement_membrane | 0.27394659 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.26467391 |
| 111 | MP0001881_abnormal_mammary_gland | 0.26235724 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.24885691 |
| 113 | MP0005197_abnormal_uvea_morphology | 0.24878689 |
| 114 | MP0002090_abnormal_vision | 0.23892757 |
| 115 | MP0005164_abnormal_response_to | 0.23891825 |
| 116 | MP0003959_abnormal_lean_body | 0.23883137 |
| 117 | MP0003878_abnormal_ear_physiology | 0.22922474 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.22922474 |
| 119 | MP0002135_abnormal_kidney_morphology | 0.22272861 |
| 120 | MP0005410_abnormal_fertilization | 0.21386109 |
| 121 | MP0000467_abnormal_esophagus_morphology | 0.18298680 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.17902137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.39319513 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.24262629 |
| 3 | * Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.03550941 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.51451846 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.46608695 |
| 6 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.34410167 |
| 7 | Xanthomatosis (HP:0000991) | 6.31633656 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.64796330 |
| 9 | Complement deficiency (HP:0004431) | 5.11036075 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.82324094 |
| 11 | Joint hemorrhage (HP:0005261) | 4.79719057 |
| 12 | Hyperammonemia (HP:0001987) | 4.70578759 |
| 13 | Epidermoid cyst (HP:0200040) | 4.51433761 |
| 14 | Hyperglycinemia (HP:0002154) | 4.47085771 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.42957014 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.41510494 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.39590016 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.37768995 |
| 19 | Ketosis (HP:0001946) | 4.33320550 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.31948648 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27977099 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.21570325 |
| 23 | Fat malabsorption (HP:0002630) | 4.06847725 |
| 24 | Hyperglycinuria (HP:0003108) | 4.05492754 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.01102872 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.01102872 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.97567098 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.86604078 |
| 29 | Abnormality of complement system (HP:0005339) | 3.72060414 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71430226 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66723070 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.64312657 |
| 33 | Nephritis (HP:0000123) | 3.54818816 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40748080 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39672661 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.35370414 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.17136005 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.16530101 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.14322027 |
| 40 | Ketoacidosis (HP:0001993) | 3.08019933 |
| 41 | Steatorrhea (HP:0002570) | 3.05236976 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.00196326 |
| 43 | Spontaneous abortion (HP:0005268) | 2.97736282 |
| 44 | Myocardial infarction (HP:0001658) | 2.91943818 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.90317076 |
| 46 | Skin nodule (HP:0200036) | 2.78164258 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.76011602 |
| 48 | Purpura (HP:0000979) | 2.74430525 |
| 49 | Lethargy (HP:0001254) | 2.67158183 |
| 50 | * Metabolic acidosis (HP:0001942) | 2.66459378 |
| 51 | Vascular calcification (HP:0004934) | 2.65190753 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.64137616 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64137616 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.61674137 |
| 55 | Osteomalacia (HP:0002749) | 2.57192508 |
| 56 | Gout (HP:0001997) | 2.56091277 |
| 57 | Acanthocytosis (HP:0001927) | 2.52375606 |
| 58 | Spastic diplegia (HP:0001264) | 2.51727910 |
| 59 | Cerebral edema (HP:0002181) | 2.49994730 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.45100059 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.43873882 |
| 62 | Mitral stenosis (HP:0001718) | 2.43827852 |
| 63 | Glomerulonephritis (HP:0000099) | 2.42428774 |
| 64 | Irritability (HP:0000737) | 2.42131238 |
| 65 | Neonatal onset (HP:0003623) | 2.40364025 |
| 66 | Reduced antithrombin III activity (HP:0001976) | 2.39061376 |
| 67 | Cholelithiasis (HP:0001081) | 2.37672935 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.35147304 |
| 69 | Malnutrition (HP:0004395) | 2.32685121 |
| 70 | Cholecystitis (HP:0001082) | 2.29434926 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.29434926 |
| 72 | Amyloidosis (HP:0011034) | 2.29140610 |
| 73 | Fair hair (HP:0002286) | 2.28001174 |
| 74 | Abnormality of the Achilles tendon (HP:0005109) | 2.27194855 |
| 75 | Pulmonary embolism (HP:0002204) | 2.22632410 |
| 76 | Arthropathy (HP:0003040) | 2.20584275 |
| 77 | Esophageal varix (HP:0002040) | 2.18246623 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18051202 |
| 79 | Gingival bleeding (HP:0000225) | 2.17057848 |
| 80 | Pancreatitis (HP:0001733) | 2.15270092 |
| 81 | Menorrhagia (HP:0000132) | 2.14889266 |
| 82 | Enlarged kidneys (HP:0000105) | 2.14582429 |
| 83 | Brushfield spots (HP:0001088) | 2.14424602 |
| 84 | Late onset (HP:0003584) | 2.13653644 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 2.13466352 |
| 86 | Vomiting (HP:0002013) | 2.12988535 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.11987569 |
| 88 | Thrombophlebitis (HP:0004418) | 2.07696157 |
| 89 | Opisthotonus (HP:0002179) | 2.03977255 |
| 90 | Alkalosis (HP:0001948) | 2.00341502 |
| 91 | Poikilocytosis (HP:0004447) | 1.99954015 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98189872 |
| 93 | Hemorrhage of the eye (HP:0011885) | 1.97908300 |
| 94 | Hyperphosphaturia (HP:0003109) | 1.97896743 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 1.97686429 |
| 96 | Rickets (HP:0002748) | 1.97255103 |
| 97 | Neonatal hypoglycemia (HP:0001998) | 1.95363676 |
| 98 | Increased serum pyruvate (HP:0003542) | 1.95273655 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 1.93852960 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.93852960 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 1.89887311 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.89324754 |
| 103 | Elevated alkaline phosphatase (HP:0003155) | 1.89258610 |
| 104 | Hypophosphatemic rickets (HP:0004912) | 1.88595718 |
| 105 | Bifid scrotum (HP:0000048) | 1.87726533 |
| 106 | Renal cortical cysts (HP:0000803) | 1.86586163 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86580263 |
| 108 | Increased serum ferritin (HP:0003281) | 1.84818233 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 1.83088568 |
| 110 | Glycosuria (HP:0003076) | 1.83088568 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82055679 |
| 112 | Status epilepticus (HP:0002133) | 1.81611745 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.81370121 |
| 114 | Proximal tubulopathy (HP:0000114) | 1.79048566 |
| 115 | Abnormality of vitamin metabolism (HP:0100508) | 1.78642242 |
| 116 | Retinal atrophy (HP:0001105) | 1.77166167 |
| 117 | Increased purine levels (HP:0004368) | 1.76061662 |
| 118 | Hyperuricemia (HP:0002149) | 1.76061662 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75796993 |
| 120 | Reticulocytosis (HP:0001923) | 1.75632033 |
| 121 | Abnormality of glycolysis (HP:0004366) | 1.74936249 |
| 122 | Gangrene (HP:0100758) | 1.73981550 |
| 123 | Abnormal tarsal ossification (HP:0008369) | 1.71183024 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.69957861 |
| 125 | Increased mean platelet volume (HP:0011877) | 1.65455179 |
| 126 | Joint swelling (HP:0001386) | 1.64204699 |
| 127 | Submucous cleft hard palate (HP:0000176) | 1.58062698 |
| 128 | Impaired platelet aggregation (HP:0003540) | 1.57106398 |
| 129 | Abnormal platelet function (HP:0011869) | 1.57106398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.35501147 |
| 2 | SIK1 | 4.63991854 |
| 3 | PDK2 | 4.62171710 |
| 4 | FGFR4 | 4.58847382 |
| 5 | ERN1 | 4.22464253 |
| 6 | INSRR | 2.97981163 |
| 7 | TAOK3 | 2.96641926 |
| 8 | ERBB4 | 2.74457202 |
| 9 | MAP2K4 | 2.35139258 |
| 10 | PKN2 | 2.34190341 |
| 11 | MST1R | 2.10219850 |
| 12 | FLT3 | 1.96636036 |
| 13 | CDK12 | 1.86130435 |
| 14 | PIK3CG | 1.84308674 |
| 15 | MAPK11 | 1.83947791 |
| 16 | PIK3CA | 1.82183413 |
| 17 | TRIB3 | 1.80001861 |
| 18 | TYK2 | 1.67192531 |
| 19 | LATS1 | 1.61782588 |
| 20 | WNK4 | 1.61717265 |
| 21 | PRPF4B | 1.56929936 |
| 22 | DAPK2 | 1.55896170 |
| 23 | AKT3 | 1.53055799 |
| 24 | ABL2 | 1.51007425 |
| 25 | PTK6 | 1.47801636 |
| 26 | FGFR2 | 1.39381374 |
| 27 | EIF2AK1 | 1.38832061 |
| 28 | FRK | 1.37314984 |
| 29 | NEK9 | 1.32399845 |
| 30 | EEF2K | 1.31825109 |
| 31 | KDR | 1.31781166 |
| 32 | PINK1 | 1.22388742 |
| 33 | JAK2 | 1.20411046 |
| 34 | MAP3K7 | 1.19078722 |
| 35 | PRKAA2 | 1.12924260 |
| 36 | GRK6 | 1.10137962 |
| 37 | MAP2K3 | 1.07588127 |
| 38 | TBK1 | 1.04508434 |
| 39 | JAK1 | 0.98947477 |
| 40 | MAPK4 | 0.98547962 |
| 41 | MAP3K10 | 0.98201328 |
| 42 | ERBB2 | 0.97254458 |
| 43 | MAP3K14 | 0.95409057 |
| 44 | PRKCZ | 0.93531811 |
| 45 | STK38L | 0.93131432 |
| 46 | PDGFRA | 0.87328761 |
| 47 | NTRK3 | 0.85669198 |
| 48 | EPHB1 | 0.84909346 |
| 49 | SMG1 | 0.84251178 |
| 50 | MAP3K3 | 0.83960457 |
| 51 | MET | 0.83905929 |
| 52 | MAPK12 | 0.82510764 |
| 53 | MAPK15 | 0.82270439 |
| 54 | CDK6 | 0.81372918 |
| 55 | TIE1 | 0.79313695 |
| 56 | MAP3K11 | 0.79209394 |
| 57 | PRKACG | 0.76629182 |
| 58 | CDK7 | 0.74875357 |
| 59 | DYRK1B | 0.73305869 |
| 60 | SGK1 | 0.72495278 |
| 61 | MAPKAPK3 | 0.71358520 |
| 62 | CSK | 0.71258992 |
| 63 | MAP3K2 | 0.70858515 |
| 64 | EPHA3 | 0.69939772 |
| 65 | GSK3A | 0.69827299 |
| 66 | MAP2K6 | 0.69305638 |
| 67 | CAMK2G | 0.69164124 |
| 68 | TYRO3 | 0.67991217 |
| 69 | SGK3 | 0.67252386 |
| 70 | PRKAA1 | 0.66658058 |
| 71 | CSNK1E | 0.65704327 |
| 72 | CAMK1D | 0.65403521 |
| 73 | FGFR1 | 0.65010745 |
| 74 | PRKG1 | 0.65000806 |
| 75 | NME2 | 0.60275075 |
| 76 | STK38 | 0.60150294 |
| 77 | RIPK1 | 0.59868262 |
| 78 | TGFBR2 | 0.59250599 |
| 79 | MAPK7 | 0.58229067 |
| 80 | IRAK3 | 0.57933669 |
| 81 | PTK2 | 0.57143832 |
| 82 | SIK2 | 0.56202522 |
| 83 | CSF1R | 0.55650402 |
| 84 | FGFR3 | 0.55501123 |
| 85 | NEK1 | 0.54705190 |
| 86 | KSR2 | 0.54503959 |
| 87 | PDPK1 | 0.54370582 |
| 88 | EPHA4 | 0.53861327 |
| 89 | IKBKE | 0.53522040 |
| 90 | PRKACA | 0.52691077 |
| 91 | PRKCQ | 0.52267481 |
| 92 | CSNK1G1 | 0.51840137 |
| 93 | RPS6KA3 | 0.51546435 |
| 94 | CSNK1D | 0.51545139 |
| 95 | MAP3K12 | 0.50053690 |
| 96 | SGK2 | 0.50012792 |
| 97 | DDR2 | 0.47947350 |
| 98 | TAOK2 | 0.47764272 |
| 99 | AKT2 | 0.47190636 |
| 100 | GRK1 | 0.44796419 |
| 101 | SRC | 0.44729328 |
| 102 | NEK6 | 0.44323028 |
| 103 | CSNK2A2 | 0.43740421 |
| 104 | IGF1R | 0.43665654 |
| 105 | STK16 | 0.43280322 |
| 106 | MAP3K5 | 0.43174581 |
| 107 | MAP3K13 | 0.42095294 |
| 108 | RET | 0.41980056 |
| 109 | MAP2K1 | 0.41182999 |
| 110 | CDK4 | 0.40964574 |
| 111 | PRKCG | 0.40920815 |
| 112 | RPS6KB1 | 0.40918416 |
| 113 | SGK223 | 0.40457347 |
| 114 | SGK494 | 0.40457347 |
| 115 | CSNK2A1 | 0.39533319 |
| 116 | ICK | 0.38097314 |
| 117 | PRKCB | 0.37679215 |
| 118 | MAP3K6 | 0.35829338 |
| 119 | PIM2 | 0.35576261 |
| 120 | BRSK2 | 0.35186366 |
| 121 | MAPK10 | 0.34844028 |
| 122 | PDK1 | 0.34368181 |
| 123 | MTOR | 0.34143939 |
| 124 | PBK | 0.33763717 |
| 125 | CAMK4 | 0.32870683 |
| 126 | PKN1 | 0.32741937 |
| 127 | CSNK1G2 | 0.32063479 |
| 128 | EGFR | 0.31255534 |
| 129 | PRKACB | 0.30920624 |
| 130 | MYLK | 0.30851065 |
| 131 | CSNK1G3 | 0.29154498 |
| 132 | PDK3 | 0.28785101 |
| 133 | PDK4 | 0.28785101 |
| 134 | IRAK2 | 0.26788085 |
| 135 | PRKCA | 0.26135436 |
| 136 | MAP3K1 | 0.25460223 |
| 137 | LATS2 | 0.24790996 |
| 138 | IRAK1 | 0.23616142 |
| 139 | MAP2K2 | 0.21311749 |
| 140 | PAK3 | 0.20147226 |
| 141 | ABL1 | 0.20125494 |
| 142 | CSNK1A1L | 0.19891490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.48480689 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65619466 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46182858 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41049676 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13960871 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71877290 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70473959 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69694357 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66249413 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58633051 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49990317 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41319316 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29319831 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18029373 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14883862 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09421504 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96276484 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95887709 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93977219 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93897576 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92505208 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86823109 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81075646 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.79518676 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78499065 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73808448 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73764038 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72241298 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70373498 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66788363 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65572367 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59633482 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56611467 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.49901336 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38202520 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38072402 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37026901 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33645377 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27646661 |
| 40 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25122949 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24383087 |
| 42 | * Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23879205 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22469733 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.18091025 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17552975 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14775028 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14580551 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04967388 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04503540 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99731013 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97949531 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97514530 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95189251 |
| 54 | * Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93817023 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89727629 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88846303 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87122892 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86512160 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82877138 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76355222 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70925201 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67974524 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65531516 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57730255 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51774340 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50870170 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46262228 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36674402 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.30994823 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.30444254 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29067279 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24923662 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24734943 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24616675 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22825679 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22190367 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21577020 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19672281 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15219122 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09525199 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02146103 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2638465 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | -0.2521151 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2511399 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2397980 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2326720 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2203603 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2112268 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2109960 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1855938 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1855736 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1850748 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1767938 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1695768 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1659218 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1579526 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1553596 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1538425 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1465260 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1391513 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1277874 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1035252 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0961940 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0857802 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0798856 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0673825 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0341119 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | -0.0012001 |

